Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2004 by Trimeris.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Trimeris
ClinicalTrials.gov Identifier:
NCT00048217
First received: October 28, 2002
Last updated: June 23, 2005
Last verified: July 2004

October 28, 2002
June 23, 2005
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00048217 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102
Not Provided

Patients who complete study T1249-102 (must be currently failing a T-20 containing regimen to participate in this study) will receive T-1249 at a dose of 200mg daily in combination with a background antiretroviral regimen for 96 weeks. Only patients that participated in study T1249-102 can participate in study T1249-105.

Not Provided
Interventional
Phase 1
Phase 2
Allocation: Randomized
Masking: Open Label
Primary Purpose: Treatment
HIV Infections
Drug: T-1249
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Completion T1249-102;
  • Currently failing a T-20 containing regimen

Exclusion Criteria:

  • Non-completion of T1249-102.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00048217
T1249-105
Not Provided
Not Provided
Trimeris
Not Provided
Not Provided
Trimeris
July 2004

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP